MedPath

Efficacy and safety of cannabis oil (Deja formula) use for Insomnia: A quasi-experimental study

Phase 1
Completed
Conditions
patients diagnosed by a physician with insomnia, occurring for three months or more.
Cannabis oil, insomnia, safety
Registration Number
TCTR20240612004
Lead Sponsor
none
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
72
Inclusion Criteria

Criteria are as follows.
1. patients diagnosed by a physician with insomnia
2. Aged 25-60 years
3. Occurring at least three times per week, persisting for three months or more

Exclusion Criteria

Criteria are symptoms or diseases of individuals as follows.
1. Psychiatric disorders
2. Dementia
3. Substance addiction
4. Sleep apnea, and
5. Severe or uncontrolled chronic diseases

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Efficacny and safety of treatment 4 weeks Insomnia Severity Index, Sleep Quality Index, and quality of life scores
Secondary Outcome Measures
NameTimeMethod
side effects or adverse reactions 4 weeks Form for recording any side effects or adverse reactions.
© Copyright 2025. All Rights Reserved by MedPath